General Information of This Drug (ID: DM0759M)

Drug Name
N91115   DM0759M
Synonyms
Cavosonstat; UNII-O2Z8Q22ZE4; O2Z8Q22ZE4; Cavosonstat [USAN]; Cavosonstat (USAN); 1371587-51-7; 3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid; SCHEMBL1289569; CHEMBL3989910; BXSZILNGNMDGSL-UHFFFAOYSA-N; AKOS030527843; D10916; N-91115; 3-Chloro-4-(6-hydroxy-2-quinolinyl)benzoic acid; Benzoic acid, 3-chloro-4-(6-hydroxy-2-quinolinyl)-
Indication
Disease Entry ICD 11 Status REF
Cystic fibrosis CA25 Phase 2 [1]
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
N91115 + Rifampicin DCY8T6Q Rifampicin Drug Interaction Potentiation [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02500667) A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects